Primary Progressive Multiple Sclerosis (PPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (PERSEUS)

NCT04458051 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

767

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Progressive Multiple Sclerosis

Interventions

DRUG: Tolebrutinib
DRUG: Placebo

Sponsor

Sanofi